Shenhuang Granules for patients with sepsis: study protocol of a multicenter, randomized, double-blind, placebo-controlled clinical trial.

ABSTRACT:

Background

Sepsis is a life-threatening condition characterized by organ dysfunction due to a dysregulated host response to infection, with a persistently high mortality rate. In recent years, the role of Traditional Chinese Medicine in treating sepsis has gained recognition both domestically and internationally. Shenhuang Granules (SHG), composed of six ingredients: Panax ginseng C.A.Mey. (Ginseng Radix et Rhizoma), Rheum palmatum L. (Rhei Radix et Rhizoma), Sargentodoxa cuneata (Oliv.) Rehder & E.H.Wilson (Sargentodoxae Caulis), Taraxacum mongolicum Hand.-Mazz. (Taraxaci Herba), Aconitum carmichaelii Debeaux (Aconiti Lateralis Radix Praeparata), and Whitmania pigra (Whitman, 1884) (Hirudo), has been reported to strengthen and consolidate

SUBMITTER: Shen MY 

PROVIDER: S-EPMC12678277 | biostudies-literature | 2025

REPOSITORIES: biostudies-literature